Fundación Canaria Rafael Clavijo para la Investigación Biomédica
Quick facts
Marketed products
- IV trivalent saccharose hydroxide ferrous
- Macrogol 3350 plus ascorbic acid · Gastroenterology
Macrogol 3350 plus ascorbic acid is an osmotic laxative bowel preparation that draws water into the intestinal lumen to promote evacuation, with ascorbic acid enhancing tolerability and reducing volume requirements.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Fundación Canaria Rafael Clavijo para la Investigación Biomédica portfolio CI brief
- Fundación Canaria Rafael Clavijo para la Investigación Biomédica pipeline updates RSS
Frequently asked questions about Fundación Canaria Rafael Clavijo para la Investigación Biomédica
What are Fundación Canaria Rafael Clavijo para la Investigación Biomédica's marketed drugs?
Top marketed products include IV trivalent saccharose hydroxide ferrous, Macrogol 3350 plus ascorbic acid.
Related
- IV trivalent saccharose hydroxide ferrous
- Macrogol 3350 plus ascorbic acid · Gastroenterology
- Sector hub: All tracked pharma companies